Home » Topics » Regulatory » Patents

Patents
RSS

BMS claims new beta3-adrenoceptor agonists

Jan. 21, 1998

Antiviral agents that inhibit virus-host cell fusion pursued by Lilly

Jan. 21, 1998

Boehringer Ingelheim develops new antiplatelet agents

Jan. 21, 1998

Vertex describes new MDR-modulating and neuritogenic agents

Jan. 21, 1998

Novel antifungal peptides isolated by Hoechst Marion Roussel

Jan. 21, 1998

VEGF and FGF receptor TK inhibitors from Zeneca

Jan. 20, 1998

SmithKline Beecham develops Lp-PLA2 inhibitors for atherosclerosis

Jan. 20, 1998

MS&D reveals new class of antimigraine agents

Jan. 20, 1998

Lilly discloses new agents for influenza

Jan. 20, 1998

Novel semisynthetic macrolides prepared at Abbott

Jan. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.